Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber. It also provides specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous chemical products
Sub-IndustryCommodity Chemicals
SectorBasic Materials
Phone617-345-0100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.34 billion
Profitability
Miscellaneous
Employees4,500
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable
Cabot (NYSE:CBT) Frequently Asked Questions
What is Cabot's stock symbol?
Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."
How often does Cabot pay dividends? What is the dividend yield for Cabot?
Cabot declared a quarterly dividend on Friday, January 10th. Shareholders of record on Friday, February 28th will be paid a dividend of $0.35 per share on Friday, March 13th. This represents a $1.40 annualized dividend and a yield of 3.24%. The ex-dividend date is Thursday, February 27th. View Cabot's Dividend History.
How will Cabot's stock buyback program work?
Cabot announced that its board has approved a share repurchase program on Monday, July 16th 2018, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 10.3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
How were Cabot's earnings last quarter?
Cabot Corp (NYSE:CBT) issued its earnings results on Monday, February, 3rd. The specialty chemicals company reported $0.69 EPS for the quarter, missing the Zacks' consensus estimate of $0.73 by $0.04. The specialty chemicals company earned $727 million during the quarter, compared to analyst estimates of $772.38 million. Cabot had a return on equity of 18.47% and a net margin of 3.98%. Cabot's revenue for the quarter was down 11.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.87 EPS. View Cabot's Earnings History.
When is Cabot's next earnings date?
What guidance has Cabot issued on next quarter's earnings?
Cabot issued an update on its FY20 earnings guidance on Monday, February, 3rd. The company provided earnings per share guidance of $3.60-3.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.80.
What price target have analysts set for CBT?
6 equities research analysts have issued 1-year price targets for Cabot's stock. Their forecasts range from $41.00 to $52.00. On average, they expect Cabot's stock price to reach $46.67 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price. View Analyst Price Targets for Cabot.
What is the consensus analysts' recommendation for Cabot?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cabot.
Has Cabot been receiving favorable news coverage?
Press coverage about CBT stock has been trending positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cabot earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Cabot.
Are investors shorting Cabot?
Cabot saw a increase in short interest in January. As of January 31st, there was short interest totalling 898,400 shares, an increase of 12.4% from the January 15th total of 799,600 shares. Based on an average daily volume of 278,300 shares, the days-to-cover ratio is currently 3.2 days. Approximately 1.6% of the company's shares are sold short. View Cabot's Current Options Chain.
Who are some of Cabot's key competitors?
What other stocks do shareholders of Cabot own?
Who are Cabot's key executives?
Cabot's management team includes the folowing people:
- Mr. Sean D. Keohane, Pres, CEO & Director (Age 52)
- Ms. Erica McLaughlin, Sr. VP & CFO (Age 43)
- Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 57)
- Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 49)
- Mr. Patrick M. Prevost, Advisor & Director (Age 64)
Who are Cabot's major shareholders?
Cabot's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include LSV Asset Management (4.94%), Earnest Partners LLC (4.63%), Bank of New York Mellon Corp (4.22%), Victory Capital Management Inc. (2.59%), State Street Corp (2.58%) and Victory Capital Management Inc. (2.57%). Company insiders that own Cabot stock include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot.
Which institutional investors are selling Cabot stock?
CBT stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bank of New York Mellon Corp, State Street Corp, Bank of America Corp DE, Los Angeles Capital Management & Equity Research Inc., Loomis Sayles & Co. L P, Credit Suisse AG and Goldman Sachs Group Inc.. View Insider Buying and Selling for Cabot.
Which institutional investors are buying Cabot stock?
CBT stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Earnest Partners LLC, AJO LP, Renaissance Technologies LLC, Man Group plc, AQR Capital Management LLC and Thrivent Financial for Lutherans. View Insider Buying and Selling for Cabot.
How do I buy shares of Cabot?
Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cabot's stock price today?
One share of CBT stock can currently be purchased for approximately $43.16.
How big of a company is Cabot?
Cabot has a market capitalization of $2.45 billion and generates $3.34 billion in revenue each year. The specialty chemicals company earns $157 million in net income (profit) each year or $3.91 on an earnings per share basis. Cabot employs 4,500 workers across the globe.View Additional Information About Cabot.
What is Cabot's official website?
How can I contact Cabot?
Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected]
MarketBeat Community Rating for Cabot (NYSE CBT)
MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
